Encefalopatía tóxica por procedimiento abortivo con rivanol. Presentación de un caso

García Ortega, Juan A.
Rev. cuba. obstet. ginecol ; 7(4): 389-93, oct.-dic. 1981. ilus
Artículo en Español | CUMED | ID: cum-6207

Documentos relacionados

  1. Toxicity of abortifacients: A review for physicians in the post roe era.
  2. Toxicities of herbal abortifacients.
  3. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
  4. The "Abortion Pill" Misoprostol in Brazil: Women's Empowerment in a Conservative and Repressive Political Environment.
  5. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
  6. Short versus Standard Mifepristone and Misoprostol Regimen for Second- and Third-Trimester Termination of Pregnancy for Fetal Anomaly.
  7. Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
  8. Termination of pregnancy in the second trimester - the course of different therapy regimens.
  9. Counselling before first trimester abortion and acceptability of the procedure: results from a Slovenian cross-sectional study.
  10. Medical abortions in adolescent girls.